- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01087060
Detection of Renal Malignancy of Complicated Renal Cysts
Does Hounsfield Unit (HU) Predict the Detection of Cystic Renal Malignancy of Complicated Renal Cysts?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients who were diagnosed as renal cysts
- available serial follow-up data of CT scan
- all CT imaging included non-enhanced (NEP), corticomedullary (CMP), and early excretory phase (EEP) scans. The scan delay times should range from 30 to 40 seconds for CMP scans and from 120 to 180 seconds for EEP scans.
Exclusion Criteria:
- cases diagnosed by only US/MR
- no serial CT images
- cysts of autosomal dominant adult polycystic kidney disease
- cysts less than 1cm in diameter (difficult to evaluate accurately)
- follow-up period less than 1 yr in the patients who had no surgery
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
cysts surgically removed
|
|
|
cysts under surveillance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
additional diagnostic criteria of CT to diagnose and predict the detection and recurrence of cystic RCC in the patients with complicated renal cysts
|
First, the primary outcomes is to determine cut-off values of maximal HU and the maximal gap of HU (HU of early excretory phase minus that of non-enhanced phase in CT scan)to predict the detection of renal malignancy. Some clinical factors (age, height, body weight, etc) were also included in the analysis. Second, the above-mentioned factors were included in the analysis of risk factors for recurrence of complicated renal cysts to determine the cut-off values. |
Secondary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
informative to determine the time of operation and which is better for a patient with a complicated cyst between partial or radical nephrectomy
|
The cut-off values would show a guideline to determine the time of operation for a patient with complicated renal cysts, namely, the nephrectomy should be performed earlier if the patient is included in the high-risk group.
Furthermore, the cut-off value would be helpful in the determination in what operation would be proper to the patient.
A partial nephrectomy would be more beneficial to every patient than radical nephrectomy, however, if the patient is in the high-risk group for early recurrence, the patient should undergo 'radical' nephrectomy first for complicated renal cysts.
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bosniak
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carcinoma, Renal Cell
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma and other conditionsUnited States
-
PfizerRecruitingCarcinoma, Renal Cell | Clear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Metastatic Renal Cell Cancer | Renal Cancer | Advanced Renal Cell Carcinoma | Renal Neoplasm | Advanced or Metastatic Renal Cell Carcinoma | Clear-cell Metastatic Renal Cell Carcinoma | Carcinoma, Renal Cell, Advanced and other conditionsUnited States, Japan, Spain, Australia, China
-
Osel, Inc.National Cancer Institute (NCI); City of Hope Medical Center; Miyarisan Pharmaceuticals...RecruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Advanced Sarcomatoid Renal...United States
-
Jinling Hospital, ChinaNot yet recruitingMetastatic Clear Cell Renal Cell CarcinomaChina
-
NYU Langone HealthNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Sarcomatoid Renal Cell CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterUnited States Department of DefenseRecruitingMetastatic Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Locally Advanced Clear Cell Renal Cell Carcinoma | Locally Advanced Sarcomatoid Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
Clinical Trials on partial or radical nephrectomy
-
Yonsei UniversityRecruitingClear Renal Cell Cancer (< 7cm Size)Korea, Republic of
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingUrolithiasisRussian Federation
-
Samsun Liv HospitalOndokuz Mayıs UniversityCompletedKidney Neoplasms | Urologic Neoplasms | Renal Cell Carcinoma | Surgery | Kidney Injury | Renal Cancer | Oncology | Urologic Cancer | Renal Neoplasm | Kidney IschemiaTurkey
-
Rob Surgical Systems S.L.Completed
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaNot yet recruitingRenal Cancer | Prostate Cancer (Adenocarcinoma)Italy
-
Rob Surgical Systems S.L.CompletedNephrectomy | ProstatectomySpain
-
University Hospital, BordeauxRecruitingKidney CancerFrance, French Guiana, Belgium, Reunion
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaRecruiting
-
Samsung Medical CenterUnknownRenal Cell CarcinomaKorea, Republic of